Benoit Chardon

No más puestos en curso

Fortuna: 368 489 $ al 30/04/2024

Health Technology

Perfil

Benoit Chardon worked as Vice President-Global Marketing at GC Aesthetics Plc.
He also worked as Chief Commercial Officer at Allurion Technologies, Inc.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
ALLURION TECHNOLOGIES, INC. 0.42%	19/04/2024	199 183 ( 0.42% )	368 489 $	30/04/2024

Antiguos cargos conocidos de Benoit Chardon.

Empresas	Cargo	Fin
ALLURION TECHNOLOGIES INC.	Corporate Officer/Principal	31/12/2023
GC Aesthetics Plc GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.	Ventas & Marketing	-

Ver el detalle de la experiencia de Benoit Chardon.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Benoit Chardon.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ALLURION TECHNOLOGIES INC.	Health Technology

Empresas privadas	1
GC Aesthetics Plc GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.	Health Technology